Live feed
Filing
SC 13D
SC 13D0001193125-16-523300·Corvus Pharmaceuticals, Inc.
Schedule 13D ownership disclosure
Corvus Pharmaceuticals Inc
Security class unavailable · CUSIP: 221015100
Event date: 2016-03-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 15.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-16-523300
- Form type
- SC 13D
- Filer
- Corvus Pharmaceuticals, Inc.
- CIK
- CIK 1626971
- Filed
- Mar 30, 2016
- Reporting period
- Mar 29, 2016
- Description
- Schedule 13D beneficial ownership